DAFNA Capital Management LLC
13F filer · CIK 1389933 · Los Angeles, CA
Summary
DAFNA Capital Management LLC reported $524.36M across 88 positions in its 13F for 2026 Q2, filed Aug 14, 2026. The largest holdings are RVMD (20.1%), XBI (5.9%), CMPS (5.4%). Versus 2026 Q1, leaving options aside, it opened 17 new positions, added to 17, trimmed 26 and sold out of 12.
Reported value$524.36M
Positions88
Report period2026 Q2
FiledAug 14, 2026
New positions17
Added17
Trimmed26
Sold out12
Top 25 holdings
By reported value, options listed separately · change vs 2026 Q1
Weight 20.1%Value $105.37MPrice $204.48Shares 563K -3.11%Since Jun 30 +9.18%
Weight 5.9%Value $31.10MPrice $156.81Shares 197K -38.30%Since Jun 30 -0.91%
Weight 5.4%Value $28.47MPrice $12.96Shares 2.01M -16.82%Since Jun 30 -8.41%
Weight 4.5%Value $23.53MPrice $1.25Shares 13.68MSince Jun 30 -27.33%
Weight 4.2%Value $22.23MPrice $59.24Shares 318K +92.75%Since Jun 30 -15.14%
Weight 3.6%Value $19.01MPrice $20.81Shares 739K +132.03%Since Jun 30 -19.09%
Weight 3.5%Value $18.53MPrice $37.86Shares 497K +4.30%Since Jun 30 +1.58%
Weight 3.2%Value $16.72MPrice $58.05Shares 597KSince Jun 30 +107.47%
Weight 2.9%Value $15.14MPrice $37.25Shares 251KSince Jun 30 -38.29%
Weight 2.8%Value $14.65MPrice $65.64Shares 172K -20.92%Since Jun 30 -22.95%
Weight 2.6%Value $13.62MPrice $25.65Shares 442K -0.45%Since Jun 30 -16.80%
Weight 2.5%Value $12.93MPrice $228.07Shares 48KSince Jun 30 -14.49%
Weight 1.9%Value $9.74MPrice $138.35Shares 58K -18.19%Since Jun 30 -17.91%
Weight 1.8%Value $9.65MPrice $42.44Shares 209K -16.40%Since Jun 30 -8.12%
Weight 1.8%Value $9.42MPrice $132.84Shares 62K +469.18%Since Jun 30 -12.75%
Weight 1.8%Value $9.22MPrice $39.19Shares 227K +102.09%Since Jun 30 -3.54%
Weight 1.6%Value $8.46MPrice $18.56Shares 285K -32.43%Since Jun 30 -37.49%
Weight 1.5%Value $8.10MPrice $211.04Shares 43K -31.40%Since Jun 30 +10.96%
Weight 1.4%Value $7.33MPrice $18.24Shares 335K +54.24%Since Jun 30 -16.58%
Weight 1.2%Value $6.13MPrice $10.15Shares 171KSince Jun 30 -71.68%
Weight 1.2%Value $6.12MPrice $3.14Shares 2.01M -1.03%Since Jun 30 +2.95%
Weight 1.1%Value $5.88MPrice $1.65Shares 2.40M -1.39%Since Jun 30 -32.65%
Weight 1.1%Value $5.81MPrice $86.64Shares 86KSince Jun 30 +28.64%
Weight 1.1%Value $5.76MPrice $33.46Shares 150K -0.66%Since Jun 30 -13.16%
Weight 1.0%Value $5.45MPrice $5.37Shares 845KSince Jun 30 -16.74%
| Stock | Weight | Value | Since Jun 30 | Shares change | Action |
|---|---|---|---|---|---|
| 20.1% | $105.37M | +9.18% | -3.11% | Trim | |
| 5.9% | $31.10M | -0.91% | -38.30% | Trim | |
| 5.4% | $28.47M | -8.41% | -16.82% | Trim | |
| 4.5% | $23.53M | -27.33% | — | Hold | |
| 4.2% | $22.23M | -15.14% | +92.75% | Add | |
| 3.6% | $19.01M | -19.09% | +132.03% | Add | |
| 3.5% | $18.53M | +1.58% | +4.30% | Add | |
| 3.2% | $16.72M | +107.47% | — | Hold | |
| 2.9% | $15.14M | -38.29% | — | Hold | |
| 2.8% | $14.65M | -22.95% | -20.92% | Trim | |
| 2.6% | $13.62M | -16.80% | -0.45% | Trim | |
| 2.5% | $12.93M | -14.49% | — | New | |
| 1.9% | $9.74M | -17.91% | -18.19% | Trim | |
| 1.8% | $9.65M | -8.12% | -16.40% | Trim | |
| 1.8% | $9.42M | -12.75% | +469.18% | Add | |
| 1.8% | $9.22M | -3.54% | +102.09% | Add | |
| 1.6% | $8.46M | -37.49% | -32.43% | Trim | |
| 1.5% | $8.10M | +10.96% | -31.40% | Trim | |
| 1.4% | $7.33M | -16.58% | +54.24% | Add | |
| 1.2% | $6.13M | -71.68% | — | Hold | |
| 1.2% | $6.12M | +2.95% | -1.03% | Trim | |
| 1.1% | $5.88M | -32.65% | -1.39% | Trim | |
| 1.1% | $5.81M | +28.64% | — | Hold | |
| 1.1% | $5.76M | -13.16% | -0.66% | Trim | |
| 1.0% | $5.45M | -16.74% | — | Hold |
Weight is the share of the reported 13F value, including options at notional value. “Since Jun 30” compares the latest close with the quarter-end price implied by the filing (value ÷ shares).
Largest buys in 2026 Q2
Largest sells in 2026 Q2
ASCENDIS PHARMA A/SNo ticker match≈ $5.92MSold
Source: SEC Form 13F, values as reported by the filer. Filings lag up to 45 days after quarter end and cover only certain long positions. Research only, not investment advice.